Invention Grant
- Patent Title: Growth hormones with prolonged in-vivo efficacy
- Patent Title (中): 生长激素具有延长的体内功效
-
Application No.: US14132919Application Date: 2013-12-18
-
Publication No.: US08779109B2Publication Date: 2014-07-15
- Inventor: Carsten Behrens , Nils Langeland Johansen , Henrik Sune Andersen , Leif Noerskov-Lauritsen
- Applicant: Novo Nordisk Health Care AG
- Applicant Address: CH Zurich
- Assignee: Novo Nordisk Health Care AG
- Current Assignee: Novo Nordisk Health Care AG
- Current Assignee Address: CH Zurich
- Agent Jianjie Hu
- Priority: EP10151405 20100122
- Main IPC: A61K38/24
- IPC: A61K38/24 ; A61K38/27
Abstract:
The invention relates to growth hormone compounds with a protracted profile. The effect is obtained by linking an albumin binding residue via a hydrophilic spacer to growth hormone variants. Further described are methods of preparing and using such compounds. These growth hormone compounds are based on there althered profile considered particular useful in therapy.
Public/Granted literature
- US20140107324A1 Growth Hormones with Prolonged In-Vivo Efficacy Public/Granted day:2014-04-17
Information query
IPC分类:
